This is consistent with the fact that activation of NANOG and MYC targeted genes is associated with poorly differentiated tumors [33], and the poorly differentiated histology of HPV+ HNSCC tumors [3]. The gene discussed is NANOG; the disease is head and neck squamous cell carcinoma.